A recent retrospective study published in CHEST evaluated the effects of cystic fibrosis transmembrane conductance regulator ...

A new study from The Hospital for Sick Children (SickKids) reveals the process underlying protein organization on cell ...

A new study from The Hospital for Sick Children (SickKids) reveals the process underlying protein organization on cell membranes, a finding which ...

为探究囊性纤维化（CF）患者嗅觉丧失原因，研究人员开展相关研究，发现 CFTR 影响嗅觉上皮细胞增殖和 OR 表达，揭示了 CF 导致嗅觉丧失的新机制。 在生活中，我们常常凭借嗅觉感知周围的美好，比如花朵的芬芳、美食的香气。然而，对于囊性纤维化（Cystic Fibrosis，CF）患者来说，嗅觉却成了一种 “奢侈品”。CF ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic ...

A recent retrospective study published in CHEST(Opens in a new window) evaluated the effects of cystic fibrosis transmembrane conductance regulator (CFTR) modulator use on pregnancy outcomes in ...

Vertex Pharmaceuticals’ triple combination cystic fibrosis (CF) treatment has been approved by the Medicines and Healthcare ...

A recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR ...

In two randomised phase 3 studies involving 480 participants aged 12 years and over, ivacaftor/tezacaftor/vanzacaftor was ...

UK MHRA approves Vertex’s Alyftrek, a once-daily next-in-class CFTR modulator to treat cystic fibrosis: London Monday, March 10, 2025, 10:00 Hrs [IST] Vertex Pharmaceuticals, a ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Alyftrek (triple combination medicine ...

The patients of cystic fibrosis (CF), their families, and public health experts are pinning their hopes on the expected outcome from the Karnataka High Court regarding availability of affordable ...